Bank of New York Mellon’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,308
| Closed | -$50K | – | 4494 |
|
|
2021
Q1 | $50K | Buy |
+13,308
| New | +$50K | ﹤0.01% | 4260 |
|
|
2019
Q4 | – | Sell |
-3,009
| Closed | -$32K | – | 4243 |
|
|
2019
Q3 | $32K | Sell |
3,009
-361
| -11% | -$3.84K | ﹤0.01% | 4145 |
|
|
2019
Q2 | $57K | Sell |
3,370
-13,452
| -80% | -$228K | ﹤0.01% | 4097 |
|
|
2019
Q1 | $567K | Buy |
16,822
+910
| +6% | +$30.7K | ﹤0.01% | 3488 |
|
|
2018
Q4 | $465K | Sell |
15,912
-68
| -0.4% | -$1.99K | ﹤0.01% | 3521 |
|
|
2018
Q3 | $985K | Buy |
15,980
+1,015
| +7% | +$62.6K | ﹤0.01% | 3260 |
|
|
2018
Q2 | $1.1M | Buy |
14,965
+4,021
| +37% | +$297K | ﹤0.01% | 3197 |
|
|
2018
Q1 | $718K | Buy |
10,944
+92
| +0.8% | +$6.04K | ﹤0.01% | 3386 |
|
|
2017
Q4 | $912K | Sell |
10,852
-1,216
| -10% | -$102K | ﹤0.01% | 3297 |
|
|
2017
Q3 | $1.39M | Sell |
12,068
-209
| -2% | -$24.1K | ﹤0.01% | 3026 |
|
|
2017
Q2 | $1.43M | Buy |
12,277
+2,684
| +28% | +$314K | ﹤0.01% | 3034 |
|
|
2017
Q1 | $1.18M | Buy |
9,593
+93
| +1% | +$11.5K | ﹤0.01% | 3146 |
|
|
2016
Q4 | $1.3M | Buy |
9,500
+861
| +10% | +$117K | ﹤0.01% | 3115 |
|
|
2016
Q3 | $1.72M | Buy |
8,639
+404
| +5% | +$80.4K | ﹤0.01% | 2851 |
|
|
2016
Q2 | $1.07M | Buy |
8,235
+2,454
| +42% | +$318K | ﹤0.01% | 3093 |
|
|
2016
Q1 | $541K | Buy |
5,781
+1,269
| +28% | +$119K | ﹤0.01% | 3402 |
|
|
2015
Q4 | $914K | Sell |
4,512
-430
| -9% | -$87.1K | ﹤0.01% | 3221 |
|
|
2015
Q3 | $719K | Buy |
4,942
+950
| +24% | +$138K | ﹤0.01% | 3359 |
|
|
2015
Q2 | $849K | Buy |
3,992
+1,642
| +70% | +$349K | ﹤0.01% | 3430 |
|
|
2015
Q1 | $544K | Buy |
+2,350
| New | +$544K | ﹤0.01% | 3574 |
|